How do you pay?

How to pay the least

From

$12.67 for 30 tablets delivered ($7.42 plus $5.25 shipping)

Generic metolazone from Cost Plus Drugs, by mail. Pick the strength on your label above for its own price.

  1. Make a free account on costplusdrugs.com. Ask your prescriber to send the prescription there, or Cost Plus Drugs can transfer it.Open Cost Plus Drugs 
  2. Order generic metolazone. It comes by mail.

Need it today? From $15.08 for 30 tablets with the free Team Cuban Card, at pharmacies that take it. Get the free card and show it there.

See the price and get the card 

A regular generic has the same active ingredient as Zaroxolyn, and the FDA requires it to work the same way.

Compare every option

Question
Brand nameZaroxolyn
Authorized genericmetolazone
Regular genericmetolazone
What you’d pay
Not soldNo longer sold
Not soldNo longer sold
From$12.67for 30 tablets at Cost Plus Drugs, with shipping
Same as Zaroxolyn?
–
–
Same active ingredientFillers and dyes can differ

Brand nameNot sold

Zaroxolyn itself isn’t sold as a prescription anymore. Its generic versions, if any, are in the other tabs.

See the regular generic →

Authorized genericNot sold now

An authorized generic of Zaroxolyn was sold before, but it isn’t sold now. Ask your pharmacist whether a regular generic (metolazone) is available.

Source: FDA, updated October 30, 2026

Regular genericWhere to buy it

Pharmacies’ own cash prices for generic metolazone, lowest first.

Pick up in storeDelivered

From each pharmacy’s own site, read November 2, 2026. Confirm the price before you fill.

About these prices

Prices change, can differ by store and state, and may depend on the strength and how many you take. With insurance, ask what your plan charges; it can be less.

Regular genericWho makes it

9 companies sell a generic of Zaroxolyn that the FDA rates a substitute. A pharmacy fills whichever one it stocks. To get a certain maker, ask for it by name; most pharmacies can order it in a day or two.

  • Advagen Pharma2.5 mg, 5 mg, 10 mg

    Has a dye: D&C Yellow No. 10 aluminum lake · Made by Rubicon Research

    How it looks, what’s in it, NDCs

    2.5 mg White to off white, round, 5 mm, marked “17 / UpArrowhead”

    PackageNDC
    Bottle of 10072888-052-01

    5 mg White to off white, round, 6 mm, marked “25 / UpArrowhead”

    PackageNDC
    Bottle of 10072888-053-01

    10 mg Pale yellow to yellow, round, 6 mm, marked “27 / UpArrowhead”

    PackageNDC
    Bottle of 10072888-054-01

    Inactive ingredients: magnesium stearate, cellulose, microcrystalline, silicon dioxide, D&C Yellow No. 10 aluminum lake

    FDA label

  • Alembic Pharmaceuticals2.5 mg, 5 mg, 10 mg

    Has dyes: D&C Red No. 27, FD&C Blue No. 2, D&C Yellow No. 10, FD&C Yellow No. 6

    How it looks, what’s in it, NDCs

    2.5 mg Pink, round, 6 mm, marked “L48”

    PackageNDC
    Bottle of 10062332-532-31
    Bottle of 100062332-532-91

    5 mg Blue, round, 6 mm, marked “L49”

    PackageNDC
    Bottle of 10062332-533-31
    Bottle of 100062332-533-91

    10 mg Yellow, round, 6 mm, marked “L50”

    PackageNDC
    Bottle of 10062332-534-31
    Bottle of 100062332-534-91

    Inactive ingredients: microcrystalline cellulose, magnesium stearate, D&C Red No. 27, FD&C Blue No. 2, D&C Yellow No. 10, FD&C Yellow No. 6

    FDA label

  • Amici Pharma2.5 mg, 5 mg, 10 mg

    Has dyes: FD&C Yellow No. 6, D&C Red No. 30 · Made by Innogenix

    How it looks, what’s in it, NDCs

    2.5 mg PEACH, round, 6 mm, marked “I121”

    PackageNDC
    Bottle of 10069292-562-01
    Bottle of 100069292-562-10

    5 mg Pink, round, 6 mm, marked “I122”

    PackageNDC
    Bottle of 10069292-564-01
    Bottle of 100069292-564-10

    10 mg Orange, round, 6 mm, marked “I123”

    PackageNDC
    Bottle of 10069292-566-01
    Bottle of 100069292-566-10

    Inactive ingredients: silicon dioxide, magnesium stearate, cellulose, microcrystalline, FD&C Yellow No. 6, D&C Red No. 30

    FDA label

  • Ingenus Pharmaceuticals2.5 mg, 5 mg, 10 mg

    Made by Renata

    Packages and NDCs

    2.5 mg Pink, round, 6 mm, marked “ZNM / 2 / 1 / 2”

    PackageNDC
    Bottle of 10050742-349-01

    5 mg White to off White, round, 6 mm, marked “ZNM / 5”

    PackageNDC
    Bottle of 10050742-350-01

    10 mg Pale Yellow to Yellow, round, 6 mm, marked “ZNM / 10”

    PackageNDC
    Bottle of 10050742-351-01

    FDA label

  • Method Pharmaceuticals2.5 mg, 5 mg, 10 mg

    Has dyes: FD&C Yellow No. 6, D&C Red No. 30 · Made by Innogenix

    How it looks, what’s in it, NDCs

    2.5 mg PEACH, round, 6 mm, marked “I121”

    PackageNDC
    Bottle of 10058657-740-01
    Bottle of 100058657-740-10

    2.5 mg PEACH, round, 6 mm, marked “I121”

    PackageNDC
    Carton of 10058657-940-01

    5 mg Pink, round, 6 mm, marked “I122”

    PackageNDC
    Bottle of 10058657-741-01
    Bottle of 100058657-741-10

    5 mg Pink, round, 6 mm, marked “I122”

    PackageNDC
    Carton of 10058657-941-01

    10 mg Orange, round, 6 mm, marked “I123”

    PackageNDC
    Bottle of 10058657-742-01
    Bottle of 100058657-742-10

    10 mg Orange, round, 6 mm, marked “I123”

    PackageNDC
    Carton of 10058657-942-01

    Inactive ingredients: silicon dioxide, magnesium stearate, cellulose, microcrystalline, FD&C Yellow No. 6, D&C Red No. 30

    FDA label

  • Mylan Institutional2.5 mg, 5 mg

    Has a dye: FD&C Yellow No. 6

    How it looks, what’s in it, NDCs

    2.5 mg Peach, round, 6 mm, marked “M / 172”

    PackageNDC
    Carton of 10051079-023-20

    5 mg Orange, round, 6 mm, marked “M / 173”

    PackageNDC
    Carton of 10051079-024-20

    Inactive ingredients: silicon dioxide, FD&C Yellow No. 6, magnesium stearate, microcrystalline cellulose

    FDA label

  • Mylan Pharmaceuticals2.5 mg, 5 mg, 10 mg

    Has dyes: FD&C Yellow No. 6, D&C Yellow No. 10, FD&C Blue No. 2

    Product page on viatris.com

    How it looks, what’s in it, NDCs

    2.5 mg Peach, round, 6 mm, marked “M / 172”

    PackageNDC
    Bottle of 1000378-6172-01

    5 mg Orange, round, 6 mm, marked “M / 173”

    PackageNDC
    Bottle of 1000378-6173-01

    10 mg Light green, round, 6 mm, marked “M / 174”

    PackageNDC
    Bottle of 1000378-6174-01

    Inactive ingredients: silicon dioxide, FD&C Yellow No. 6, magnesium stearate, microcrystalline cellulose, D&C Yellow No. 10, FD&C Blue No. 2

    FDA label

  • Sandoz2.5 mg, 5 mg, 10 mg

    Has dyes: D&C Red No. 30, FD&C Blue No. 2, D&C Yellow No. 10, FD&C Yellow No. 6

    How it looks, what’s in it, NDCs

    2.5 mg Pink, oval, 6 mm, marked “E50”

    PackageNDC
    Bottle of 1000185-5050-01
    Bottle of 10000185-5050-10

    5 mg Blue, oval, 6 mm, marked “E55”

    PackageNDC
    Bottle of 1000185-0055-01
    Bottle of 10000185-0055-10

    10 mg Yellow, oval, 6 mm, marked “E56”

    PackageNDC
    Bottle of 1000185-5600-01
    Bottle of 10000185-5600-10

    Inactive ingredients: microcrystalline cellulose, D&C Red No. 30, FD&C Blue No. 2, magnesium stearate, silicon dioxide, D&C Yellow No. 10, FD&C Yellow No. 6

    FDA label

  • Unichem Pharmaceuticals2.5 mg, 5 mg, 10 mg

    Has dyes: D&C Red No. 30, FD&C Blue No. 2, D&C Yellow No. 10, FD&C Yellow No. 6

    Product page on unichemusa.com

    How it looks, what’s in it, NDCs

    2.5 mg Pink, round, 6 mm, marked “M / 2 / 5”

    PackageNDC
    Bottle of 10076385-136-01

    5 mg Blue, round, 6 mm, marked “M / 5”

    PackageNDC
    Bottle of 10076385-137-01

    10 mg Yellow, round, 6 mm, marked “M / 10”

    PackageNDC
    Bottle of 10076385-138-01

    Inactive ingredients: microcrystalline cellulose 102, magnesium stearate, silicon dioxide, D&C Red No. 30, FD&C Blue No. 2, D&C Yellow No. 10, FD&C Yellow No. 6

    FDA label

Who sells it: FDA and Medicaid records, updated weekly. Each maker’s page, card and program is from its own site.

What it’s used for

What the FDA label says

Metolazone tablets, USP, are indicated for the treatment of salt and water retention including:

  • edema accompanying congestive heart failure;
  • edema accompanying renal diseases, including the nephrotic syndrome and states of diminished renal function.

Metolazone tablets, USP, are also indicated for the treatment of hypertension, alone or in combination with other antihypertensive drugs of a different class. MYKROX Tablets, a more rapidly available form of metolazone, are intended for the treatment of new patients with mild to moderate hypertension. A dose titration is necessary if MYKROX Tablets are to be substituted for metolazone tablets, USP, in the treatment of hypertension. See package circular for MYKROX Tablets.

Usage In Pregnancy

The routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus to unnecessary hazard. Diuretics do not prevent development of toxemia of pregnancy, and there is no evidence that they are useful in the treatment of developed toxemia.

Edema during pregnancy may arise from pathologic causes or from the physiologic and mechanical consequences of pregnancy. Metolazone tablets, USP, are indicated in pregnancy when edema is due to pathologic causes, just as it is in the absence of pregnancy (see PRECAUTIONS). Dependent edema in pregnancy resulting from restriction of venous return by the expanded uterus is properly treated through elevation of the lower extremities and use of support hose; use of diuretics to lower intravascular volume in this case is illogical and unnecessary. There is hypervolemia during normal pregnancy which is harmful to neither the fetus nor the mother (in the absence of cardiovascular disease), but which is associated with edema, including generalized edema, in the majority of pregnant women. If this edema produces discomfort, increased recumbency will often provide relief. In rare instances, this edema may cause extreme discomfort which is not relieved by rest. In these cases, a short course of diuretics may be appropriate.

Source: the FDA label for Metolazone (Method Pharmaceuticals, LLC), February 11, 2026. Full label on DailyMed